References
- Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-27. https://doi.org/10.1016/S1470-2045(06)70804-X
- Kato H, Tsuboi M, Kato Y, Ikeda N, Okunaka T, Hamada C. Postoperative adjuvant therapy for completely resected earlystage non-small cell lung cancer. Int J Clin Oncol 2005;10:157-64. https://doi.org/10.1007/s10147-005-0493-x
- Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III nonsmall- cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006. https://doi.org/10.1200/JCO.2005.04.6110
- Park YJ, Ahn YC, Lim DH, et al. Postoperative radiation therapy for chest wall invading pT3N0 non-small cell lung cancer: elective lymphatic irradiation may not be necessary. J Korean Soc Ther Radiol Oncol 2003;21:253-60.
- Gould PM, Bonner JA, Sawyer TE, Deschamps C, Lange CM, Li H. Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1999;45:91-5. https://doi.org/10.1016/S0360-3016(99)00148-0
- Doddoli C, D'Journo B, Le Pimpec-Barthes F, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg 2005;80:2032-40. https://doi.org/10.1016/j.athoracsur.2005.03.088
- Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593-602. https://doi.org/10.1097/JTO.0b013e31807a2f81
- Rena O, Massera F, Robustellini M, et al. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients. Cancer J 2010;16:176-81. https://doi.org/10.1097/PPO.0b013e3181ce474e
- Van Schil PE, Hendriks JM, Hertoghs M, Lauwers P, Choong C. Current surgical treatment of non-small-cell lung cancer. Expert Rev Anticancer Ther 2011;11:1577-85. https://doi.org/10.1586/era.11.142
- Dilege S, Toker A, Tanju S, et al. Chest wall invasion in lung cancer patients. Acta Chir Belg 2003;103:396-400. https://doi.org/10.1080/00015458.2003.11679451
- Lally BE, Detterbeck FC, Geiger AM, et al. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer 2007;110:911-7. https://doi.org/10.1002/cncr.22845
- Yoon HI, Kim YB, Lee CG, et al. Division of the N2 stage according to the multiplicity of the involved nodal stations may be necessary in the N2-NSCLC patients who are treated with postoperative radiotherapy. J Korean Soc Ther Radiol Oncol 2009;27:126-32. https://doi.org/10.3857/jkstro.2009.27.3.126
- Bogart JA, Aronowitz JN. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy. Clin Cancer Res 2005;11(13 Pt 2):5004s-5010s. https://doi.org/10.1158/1078-0432.CCR-05-9010
- Voltolini L, Rapicetta C, Luzzi L, et al. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection. Lung Cancer 2006;52:359-64. https://doi.org/10.1016/j.lungcan.2006.01.010
- Bonner JA, Spencer SA. Postoperative radiotherapy in nonsmall- cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy. J Clin Oncol 2006;24:2978-80. https://doi.org/10.1200/JCO.2006.05.8560
- Hayakawa K, Mitsuhashi N, Saito Y, et al. Impact of tumor extent and location on treatment outcome in patients with stage III non-small cell lung cancer treated with radiation therapy. Jpn J Clin Oncol 1996;26:221-8. https://doi.org/10.1093/oxfordjournals.jjco.a023218
- Riquet M, Lang-Lazdunski L, Le PB, et al. Characteristics and prognosis of resected T3 non-small cell lung cancer. Ann Thorac Surg 2002;73:253-8. https://doi.org/10.1016/S0003-4975(01)03264-7
- Satoh Y, Ishikawa Y, Inamura K, Okumura S, Nakagawa K, Tsuchiya E. Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis. Virchows Arch 2005;447:984-9. https://doi.org/10.1007/s00428-005-0031-2
- Lee CY, Byun CS, Lee JG, et al. The prognostic factors of resected non-small cell lung cancer with chest wall invasion. World J Surg Oncol 2012;10:9. https://doi.org/10.1186/1477-7819-10-9
- Patterson GA, Ilves R, Ginsberg RJ, Cooper JD, Todd TR, Pearson FG. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg 1982;34:692-7. https://doi.org/10.1016/S0003-4975(10)60911-3
- Burkhart HM, Allen MS, Nichols FC 3rd, et al. Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg 2002;123:670-5. https://doi.org/10.1067/mtc.2002.121159
- Allen MS, Mathisen DJ, Grillo HC, Wain JC, Moncure AC, Hilgenberg AD. Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 1991;51:948-51. https://doi.org/10.1016/0003-4975(91)91011-J
- Facciolo F, Cardillo G, Lopergolo M, Pallone G, Sera F, Martelli M. Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection. J Thorac Cardiovasc Surg 2001;121:649-56. https://doi.org/10.1067/mtc.2001.112826
Cited by
- Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer vol.95, pp.6, 2016, https://doi.org/10.1097/md.0000000000002795
- Deep learning for semi-automated unidirectional measurement of lung tumor size in CT vol.21, pp.1, 2015, https://doi.org/10.1186/s40644-021-00413-7